You opened your lab portal, scanned down the page, and saw low testosterone next to normal or elevated LH and FSH. You likely searched for what these numbers mean together. Blood tests rarely explain the biological feedback loops between your brain and your reproductive system. This guide provides a definitive breakdown of luteinizing hormone, follicle-stimulating hormone, and how doctors use them to identify the root cause of male hormone changes.
Clinical Foundations of Gonadotropin and Androgen Testing
Medical guidelines from the Endocrine Society state that testosterone levels should never be interpreted in isolation. A diagnosis of androgen deficiency requires clear clinical symptoms alongside repeatedly low early-morning fasting testosterone levels. Once low testosterone is established, measuring luteinizing hormone (LH) and follicle-stimulating hormone (FSH) is the standard method for locating the origin of the problem.
Gonadotropins act as messengers from your brain to your testes. LH signals the Leydig cells in the testes to produce testosterone. FSH acts on the Sertoli cells to support sperm development and fluid production.
When testosterone drops, a healthy pituitary gland increases its output of LH and FSH to demand more production. Because of this feedback loop, gonadotropin values must always be interpreted relative to circulating testosterone levels. An LH level that falls within the standard laboratory reference range is not necessarily healthy. If testosterone is severely low, a normal LH level demonstrates that the brain is failing to respond to the deficit.
Primary hypogonadism occurs when the testes cannot produce adequate testosterone despite strong pituitary signaling. In this scenario, LH and FSH rise above normal limits. Secondary hypogonadism occurs when the hypothalamus or pituitary gland fails to signal the testes. In central dysfunction, testosterone is low while LH and FSH remain low or inappropriately normal.
The Hypothalamic-Pituitary-Gonadal Axis Mechanics
The male endocrine system operates through a continuous feedback loop known as the hypothalamic-pituitary-gonadal (HPG) axis. The process starts in the hypothalamus at the base of the brain. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in distinct, rhythmic pulses throughout the day and night.
GnRH travels directly to the anterior pituitary gland. These pulses prompt specialized pituitary cells to synthesize and secrete LH and FSH into the bloodstream. Constant, non-pulsatile exposure to GnRH actually shuts down gonadotropin production. Medical treatments that use continuous GnRH stimulation suppress LH and FSH after a brief initial spike.
Once released, LH binds to receptors on Leydig cells in the interstitial tissue of the testes. This binding activates intracellular pathways that convert cholesterol into testosterone. Testosterone then enters local testicular tissue and broader circulation. Circulating testosterone converts partly into estradiol through the aromatase enzyme in fat tissue, bone, and the brain.
FSH binds to Sertoli cells lining the seminiferous tubules within the testes. Sertoli cells act as nurse cells that nourish developing sperm cells. In response to FSH and high local testosterone, Sertoli cells produce inhibin B. Inhibin B travels back to the anterior pituitary to reduce FSH release without significantly altering LH.
Testosterone and estradiol travel back through the bloodstream to the brain. They bind to androgen and estrogen receptors in both the hypothalamus and the pituitary. When circulating hormone levels are sufficient, they decrease the frequency of GnRH pulses and reduce pituitary LH secretion. This negative feedback mechanism maintains hormone concentrations within a stable physiological window.
Testicular Architecture and Cellular Function
The testes contain two anatomically and functionally distinct compartments. Understanding these compartments clarifies why testosterone production and fertility can change independently of each other.
The interstitial compartment surrounds the seminiferous tubules. This space contains Leydig cells, blood vessels, immune cells, and connective tissue. Leydig cells make up only a small fraction of total testicular volume. Their main responsibility is producing testosterone in response to LH stimulation.
The tubular compartment makes up the vast majority of testicular volume. This compartment contains the seminiferous tubules, where spermatogenesis occurs. Sertoli cells create a physical blood-testis barrier that protects developing sperm from harmful substances and immune attack. Developing germ cells progress through multiple stages of maturation within this protected space.
Because these compartments operate under different hormonal drivers, damage to one area does not always destroy the other. A man can experience extensive injury to the seminiferous tubules while Leydig cell function remains intact. In that situation, testosterone production remains stable, but sperm production drops and FSH rises.
Sertoli cells require both FSH and massive concentrations of intratesticular testosterone to maintain sperm production. Intratesticular testosterone concentrations are naturally dozens of times higher than levels found in general circulation. Systemic testosterone measurements do not reflect the local microenvironment inside the seminiferous tubules.
Age-Related Hormonal Shifts and Functional Axis Changes After 45
Hormone dynamics shift as men move past age 45. Total testosterone decreases at an average rate of roughly 1 percent per year, while free testosterone drops faster. These changes stem from a combination of testicular changes, central nervous system alterations, and metabolic shifts.
Leydig cell volume and responsiveness gradually decline over time. The testes become less responsive to LH stimulation, leading to a subtle reduction in testosterone output per cell. The pituitary gland often compensates by increasing baseline LH production to maintain normal circulating testosterone. This state is known as compensated or subclinical primary hypogonadism.
At the same time, the liver produces higher concentrations of sex hormone-binding globulin (SHBG). SHBG binds tightly to testosterone in the bloodstream, reducing the fraction of unbound, bioavailable hormone. A man over 50 may maintain a total testosterone number similar to his 30s while experiencing a meaningful decline in free testosterone.
The hypothalamic pulse generator also undergoes subtle shifts. GnRH pulses become less organized and lower in amplitude. Sleep architecture changes with age, bringing less deep slow-wave sleep and reduced nocturnal testosterone spikes.
These biological shifts represent natural physiological adaptations rather than a sudden disease state. You can review detailed testing methods in our male hormone testing protocols to track these age-related patterns accurately. Maintaining physical capability requires understanding how your baseline shifts across decades.
Metabolic health plays a dominant role in axis performance during midlife. Visceral fat accumulation increases aromatase activity, converting more circulating testosterone into estradiol. Higher estradiol concentrations exert added negative feedback on the hypothalamus, lowering LH secretion and suppressing testicular output. Improving body composition directly supports healthy axis function in older men.
Real-World Clinical Scenarios and Lab Pattern Interpretations
Evaluating male hormones requires matching laboratory patterns to clinical presentations. Clinicians evaluate several distinct biochemical combinations when reviewing patient blood work.
Pattern 1: Low Testosterone with High LH and High FSH
This pattern represents classic primary testicular failure. The testes have lost the ability to produce adequate testosterone and sperm despite aggressive signaling from the brain. The hypothalamus and pituitary detect low circulating androgens and open the hormonal throttle.
Common causes include genetic conditions like Klinefelter syndrome, prior testicular trauma, mumps orchitis, or radiation exposure. Toxic exposures, such as chemotherapy or certain workplace chemicals, can also destroy testicular tissue. Physical examination frequently reveals reduced testicular volume or altered testicular consistency.
In older men, this pattern can emerge after severe systemic infections or progressive vascular insufficiency to the scrotum. Treatment focuses on managing symptoms of androgen deficiency because the testes cannot be stimulated internally. Fertility preservation requires specialist evaluation, though options may be limited if germ cells are entirely absent.
Pattern 2: Low Testosterone with Low or Inappropriately Normal LH
This pattern indicates secondary or central hypogonadism. The testes may possess normal functional capacity, but the brain is failing to deliver the required hormonal stimulation. A normal-range LH is abnormal in the presence of clear testosterone deficiency.
Structural causes include non-functioning pituitary adenomas, craniopharyngiomas, infiltrative diseases like hemochromatosis, or prior head injuries. Severe central suppression can also stem from genetic conditions that disrupt GnRH synthesis or release.
When low testosterone occurs alongside low or normal LH, doctors order additional tests to evaluate pituitary function. Prolactin measurement is standard practice. If testosterone falls below 150 ng/dL, brain imaging through magnetic resonance imaging (MRI) is often used to inspect the sella turcica.
Pattern 3: Low Testosterone with Normal LH in Metabolic Overweight
This scenario represents functional axis suppression, often referred to as obesity-related secondary hypogonadism. Excess adipose tissue raises circulating cytokines and enhances aromatase expression. The resulting estrogenic feedback suppresses pituitary LH release just enough to lower total testosterone.
Visceral adiposity also lowers circulating SHBG concentrations. Lower SHBG pulls down total testosterone numbers while free testosterone may remain relatively stable. Men in this category usually have normal testicular volume and no signs of pituitary disease.
Addressing sleep apnea, improving insulin sensitivity, and reducing visceral fat often restores endogenous testosterone production. This condition is generally reversible because the cellular machinery of both the pituitary and the testes remains structurally intact. Supporting metabolic health and body composition remains the primary intervention for this pattern.
Pattern 4: Normal Testosterone with Elevated FSH
This pattern highlights the independent regulation of Sertoli and Leydig cells. The Leydig cells are producing sufficient testosterone under normal LH stimulation. The seminiferous tubules, however, have suffered isolated damage.
Because Sertoli cell function is impaired, inhibin B production drops significantly. Without inhibin B feedback, the anterior pituitary secretes high levels of FSH to stimulate the tubules. Testosterone levels remain entirely normal, and the patient may report no issues with energy or libido.
This profile is common in men with a history of undescended testicles (cryptorchidism), localized testicular heat exposure, or mild toxic insults. The primary symptom is subfertility or unexplained difficulty conceiving. Semen analysis is necessary in this scenario to evaluate actual sperm concentration and motility.
Pattern 5: Low LH and FSH After Exogenous Androgens
This profile occurs when a man uses exogenous testosterone, prohormones, or anabolic steroids. High concentrations of external androgens flood the bloodstream, triggering intense negative feedback at the hypothalamus and pituitary.
The brain halts GnRH pulsatility and shuts down the release of both LH and FSH. Without intratesticular LH signaling, Leydig cells cease endogenous testosterone synthesis. Without FSH, Sertoli cells cannot support spermatogenesis, leading to testicular atrophy and azoospermia.
When external androgens are stopped abruptly, serum testosterone crashes while gonadotropins remain fully suppressed. Recovery of natural axis pulsatility can take several months or even years depending on exposure duration. Specialist care is essential to restore pituitary-testicular communication safely.
Pattern 6: Severe Central Suppression with Visual Disturbances
This presentation represents a medical priority. A patient presents with testosterone below 150 ng/dL, undetectable or suppressed gonadotropins, chronic headaches, and changes in peripheral vision.
These findings suggest a expanding mass in the pituitary fossa compressing the optic chiasm. Prolactinomas or large non-functioning pituitary macroadenomas can physically compress gonadotroph cells and adjacent neural structures.
Immediate neuroimaging and full anterior pituitary hormone panel testing are mandatory. Treatment addresses the underlying sellar lesion through medical therapy or surgical decompression rather than standard hormone replacement.
Step-by-Step Diagnostic Framework for Hormone Evaluation
Accurate interpretation of male hormones follows a structured sequence. Rushing into treatments based on incomplete data leads to misdiagnosis and inappropriate therapies.
- Step 1: Confirm Low Testosterone
- Measure early-morning total testosterone (7:00 AM, 10:00 AM)
- Fasting state required; repeat test 1 to 4 weeks later
- Add free testosterone if SHBG abnormalities are suspected
- Step 2: Measure Gonadotropins (LH and FSH)
- Distinguish primary (elevated LH/FSH) from central (low/normal LH/FSH)
- Step 3: Evaluate Prolactin & Secondary Pituitary Markers
- Order prolactin if LH is low or normal
- Repeat mild elevations (up to 1.5x normal limit) to rule out stress artifacts
- Screen for thyroid and adrenal abnormalities
- Step 4: Structural and Specialist Evaluation
- Order pituitary MRI if testosterone 150 ng/dL or neurological signs appear
- Perform semen analysis if fertility is a goal
The first phase involves proving that testosterone deficiency exists consistently. Serum testosterone exhibits a pronounced diurnal rhythm, peaking in the early morning hours and dropping toward the evening. Blood draws must occur between 7:00 AM and 10:00 AM in a fasting state.
Acute illnesses, such as viral infections or intense sleep deprivation, temporarily suppress testosterone synthesis. Testing must take place during periods of stable baseline health. If an initial morning test shows low testosterone, a second confirmatory draw should occur one to four weeks later.
The second phase evaluates LH and FSH to classify the mechanism. If LH is elevated above the reference range, the clinician focuses on testicular pathology. If LH is low or normal, the evaluation turns toward hypothalamic-pituitary integrity and functional suppression.
The third phase investigates upstream drivers of central suppression. Prolactin measurement is standard whenever low testosterone is paired with non-elevated LH. Mild elevations up to 1.5 times the upper limit of normal are often repeated because venipuncture stress can trigger transient prolactin release.
The fourth phase determines whether structural imaging or fertility diagnostics are required. Pituitary MRI is indicated for severe secondary deficiency, persistent hyperprolactinemia, or symptoms of visual compromise. If a man desires future fertility, a comprehensive semen analysis provides direct functional data that blood tests cannot replicate. Always follow standard medical consultation guidelines when planning advanced diagnostic testing.
Modifiable Influences and Functional Recovery Strategies
Many cases of secondary axis suppression in men over 45 stem from reversible physiological factors. Identifying and resolving these factors can restore natural hormone signaling without requiring lifelong medical therapy.
Obesity remains the most common driver of functional hypogonadism in midlife. Adipose tissue expansion alters insulin sensitivity and promotes low-grade systemic inflammation. Weight reduction through structured nutrition and resistance exercise reduces aromatase activity and lowers inflammatory signaling. As visceral fat decreases, hypothalamic GnRH pulsatility improves, raising LH and restoring circulating testosterone.
Obstructive sleep apnea severely disrupts nighttime endocrine rhythms. Testosterone synthesis peaks during undisturbed rapid eye movement (REM) and slow-wave sleep stages. Repeated nocturnal oxygen desaturations and frequent micro-arousals fragment sleep architecture and blunt the nocturnal LH rise. Treating sleep apnea with continuous positive airway pressure (CPAP) therapy stabilizes nighttime oxygen levels and supports natural hormone secretion.
Medication exposures frequently suppress pituitary-gonadal communication. Chronic opioid therapy suppresses GnRH secretion at the hypothalamic level, producing opioid-induced androgen deficiency. Systemic glucocorticoids used for inflammatory conditions directly inhibit both pituitary gonadotrophs and testicular Leydig cells. Psychoactive medications, including certain antidepressants and antipsychotics, can elevate prolactin and lower gonadotropin output.
Excessive endurance exercise combined with prolonged caloric restriction can trigger functional central hypogonadism. When energy availability falls below metabolic requirements, the brain downregulates reproductive hormone output to preserve energy for vital processes. Balancing training volume with adequate caloric and micronutrient intake maintains HPG axis integrity. Building consistent habits supports long term healthy aging across your lifespan.
Prioritizing progressive resistance training helps preserve muscular and metabolic health. Lifting challenging weights maintains muscle mass, improves glucose clearance, and supports metabolic efficiency. Integrating progressive lifting into your weekly routine is a proven strategy for maintaining strength and lean muscle mass as hormone dynamics evolve.
Diagnostic Pitfalls and Widespread Misconceptions
Misinterpreting hormone panels is common in clinical practice and online forums. Avoiding these widespread errors prevents unnecessary interventions and missed diagnoses.
Misconception 1: A Normal LH Result Proves Normal Pituitary Function
A common diagnostic mistake is assuming a normal LH reading rules out pituitary problems. In a healthy endocrine system, low circulating testosterone triggers an immediate surge in LH secretion.
If total testosterone is 180 ng/dL and LH is sitting in the middle of the normal reference range, the pituitary response is inadequate. This finding represents an inappropriately normal LH value and points toward secondary hypogonadism. The reading must always be evaluated alongside circulating androgen levels.
Misconception 2: Testosterone Therapy Cures All Forms of Hormone Deficiency
Exogenous testosterone does not fix the underlying signaling problems of secondary hypogonadism. While it elevates circulating androgen levels, it shuts down endogenous LH and FSH secretion through negative feedback.
When LH and FSH drop to zero, Leydig cells stop functioning and Sertoli cells cease supporting sperm maturation. For men who wish to preserve fertility or maintain natural testicular function, exogenous testosterone is contraindicated. In secondary hypogonadism, gonadotropin therapies like human chorionic gonadotropin (hCG) or selective estrogen receptor modulators are used instead to stimulate natural production.
Misconception 3: A Single Lab Test Provides a Definitive Diagnosis
Hormone concentrations fluctuate significantly based on stress, hydration, recent meals, physical activity, and sleep quality. Relying on a single blood draw to establish hypogonadism leads to overdiagnosis and inappropriate treatment plans.
Endocrine guidelines demand at least two separate early-morning fasting measurements before confirming androgen deficiency. Repeating tests rules out transient dips caused by acute stress, minor viral infections, or poor sleep.
Misconception 4: Low LH Always Indicates a Brain Tumor
Finding low testosterone paired with low LH often causes unnecessary alarm regarding pituitary tumors. While structural lesions must be ruled out, functional suppression is far more common.
Metabolic dysfunction, significant weight gain, sleep apnea, emotional stress, and common prescription medications frequently suppress gonadotropin secretion. Structural tumors represent only a small fraction of secondary hypogonadism cases.
Misconception 5: Normal Serum Testosterone Guarantees Normal Fertility
Many men assume that normal circulating testosterone confirms normal reproductive capability. Because Leydig and Sertoli cells function in distinct testicular compartments, testosterone production can remain normal while spermatogenesis is severely impaired.
A man can have excellent physical energy, normal libido, and normal testosterone levels alongside an elevated FSH and low sperm count. Assessing fertility requires a formal semen analysis rather than relying on serum testosterone measurements.
Limitations of Current Gonadotropin Research
While the core mechanics of the HPG axis are well documented, significant gaps remain in clinical research regarding gonadotropin evaluation.
A major limitation involves standard blood draw methodology. The pituitary gland secretes LH in distinct pulses every 90 to 120 minutes. A single venipuncture captures only a single snapshot in time. A blood draw taken during a pulse trough can show low LH, while a draw taken during a pulse peak shows elevated LH. Serial blood sampling or pooled serum draws provide greater accuracy, but these techniques are rarely practical in standard outpatient clinics.
The natural history of compensated hypogonadism in aging men remains poorly understood. Some men with normal testosterone and elevated LH maintain stable hormone levels for decades without symptoms. Other men progress toward overt primary testicular failure over time. Long-term longitudinal studies have not yet identified clear biomarkers that predict which individuals will progress and which will remain stable.
Commercial at-home hormone tests that use saliva or finger-prick blood spots have introduced additional uncertainty. Salivary assays do not reliably measure peptide hormones like LH and FSH. Capillary finger-prick methods are prone to sample evaporation, tissue fluid contamination, and assay interference. Standardized serum venipuncture analyzed by accredited clinical laboratories remains the only reliable method for clinical decision-making.
Data regarding the reversibility of long-standing functional secondary hypogonadism is also limited. While moderate weight loss improves testosterone in middle-aged men, the exact degree of metabolic recovery required to normalize the axis varies widely. Controlled trials evaluating long-term axis recovery after severe obesity or chronic opioid use remain small and short in duration.
Core Takeaways and Weekly Action Steps
LH and FSH are biological feedback signals that identify whether low testosterone originates in the testes, the brain, or lifestyle-driven functional suppression. Never interpret a gonadotropin level in isolation without evaluating confirmed early-morning testosterone, clinical symptoms, and overall metabolic health.
Use this checklist to prepare for your next medical review:
- Verify your lab requisition specifies an early-morning draw between 7:00 AM and 10:00 AM in a fasting state.
- Ensure the panel includes total testosterone, free testosterone, SHBG, LH, and FSH drawn together.
- If total testosterone is low, schedule a second confirmatory test two to four weeks later before discussing treatment options.
- If repeat testing confirms low testosterone alongside low or normal LH, ask your doctor to evaluate prolactin and screen for sleep apnea.
- Review all current prescription medications, over-the-counter supplements, and recent health changes with your physician.
- If you have future fertility goals, request a comprehensive semen analysis before initiating any hormone-altering therapy.
Sources
Stay sharp
Get the word
Join our newsletter for the best writing advice and stories from the field.
